Table 1.

Effects of Anti-γδ mAb Administration on Development of Cerebral Malaria in IL-2-Treated and Infected DBA/2 Mice (n = 7/Group)

Experiment	Treatment	Cerebral malaria*
Experiment 1†	TcR γδ mAb (on days+3 and+6 after infection)	0 /7
	Isotype match control	7 /7
Experiment 2‡	TcR γδ mAb (on days−1 and+2 after infection)	6 /7
	Isotype match control	7 /7

*Cerebral malaria symptoms were examined at day 6 after infection.

^†Mice were injected with anti-γδ on days +3 and +6 after infection.

^‡Mice were given injections with anti-γδ mAb on days −1 and +2 after infection.